Table 3. Antibiotic susceptibility pattern of S. aureus isolates.

	Resistant, no. (%)			OR	95% CI	p-value
Antibiotic	MS patients (n=63)	Healthy individuals (n=35)	Total resistant (n=98)
Cefoxitin	14 (22.2)	5 (16.7)	19 (19.3)	1.714	0.581-5.242	0.426
Gentamicin	8 (12.7)	4 (11.4)	12 (12.2)	1.127	0.314-4.048	1
Erythromycin	26 (41.3)	9 (25.7)	25 (25.5)	2.030	0.818-5.038	0.186
Clindamycin	17 (26.9)	7 (20.0)	24 (17.3)	1.478	0.545-4.009	0.475
Ciprofloxacin	11 (17.5)	5 (16.7)	16 (16.3)	1.269	0.402-4.003	0.781
Co-trimoxazole	15 (23.8)	4(11.4)	19 (19.3)	2.422	0.735-7.975	0.185
Chloramphenicol	7 (11.1)	4 (11.4)	11 (11.2)	0.969	0.263-3.571	1
Rifampin	3 (4.8)	0 (0.00)	3 (3.1)	0.952	0.901-1.006	0.551
Doxycycline	23 (36.5)	8 (22.8)	31 (31.6)	1.941	0.757-4.973	0.182
Quinupristin-dalfopristin	0 (0.0)	0 (0.0)	0 (0.0)	–	–	–
Linezolid	0 (0.0)	0 (0.0)	0 (0.0)	–	–	–
Mupirocin	3 (4.8)	1 (2.8)	4 (4.1)	1.700	0.170-16.989	1
Vancomycin	0 (0.0)	0 (0.0)	0 (0.0)	–	–	–

MS – multiple sclerosis; OR – odds ratio; 95%CI – 95% confidence interval.